News & Updates

In a territory-wide, 12-year follow-up retrospective study by the University of Hong Kong, indapamide has demonstrated a low incidence of hospitalization for severe hypokalaemia in patients with hypertension. Use of sustained-release (SR) indapamide appears to lower the risk of severe hypokalaemia vs the immediate-release (IR) formulation.

Moderate consumption of virgin olive oil (VOO) daily appears to help reduce the risk of all-cause and cardiovascular mortality, reports a study. However, such effects are not found in common olive oil.

Changes in cardiorespiratory fitness (CRF) appear to predict the risk of mortality in patients with and without cardiovascular disease (CVD), suggest the results of a study.

Sodium-glucose cotransporter 2 (SGLT2) inhibitors reduce the risks of respiratory and renal diseases vs dipeptidyl peptidase-4 (DPP-4) inhibitors in patients with type 2 diabetes mellitus (T2DM), researchers from the University of Hong Kong (HKU) have reported.

Too little salt is not necessarily better for individuals with heart failure, with the results of a recent meta-analysis suggesting that sodium restriction in this population increases the risk of death.

Combination therapy with metformin and thiazolidinedione appears to be the best performing glucose-lowering medication for preventing atrial fibrillation (AF) in patients with type 2 diabetes (T2D), as shown in a study.

Revered by diet enthusiasts as a godsend in the weight loss arena, a low-carbohydrate, high-fat (LCHF*) diet appears to take the opposite pole from a cardiovascular (CV) standpoint, as researchers from Canada found high levels of bad cholesterol and apolipoprotein B (apoB) in individuals who adhered to this dietary pattern.